MaxCyte, Inc.: shareholders and insiders

MXCTNASDAQHealthcare · Services-Commercial Physical & Biological Research

Price

$1.19

November 13, 2026Market cap $127M

What Ploutos Investor adds for MaxCyte

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 15, 2025 to Jun 22, 2026, from their own Form 4 filings.

8 Form 4s

Bought on the market

–

nobody

Sold on the market

$8.3K

1 person

From Nov 15, 2025 to Nov 15, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 15, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $8.3K by 1 person

  • 2025: no buys, no sales
  • 2026: no buys, sold $8.3K by 1 person
  • Jun 17, 2026John Joseph JohnstonDirector
    Kind
  • Jun 17, 2026Rekha HemrajaniDirector
    Kind
  • Jun 17, 2026Stanley C ErckDirector
    Kind
  • Jun 17, 2026Richard DouglasDirector
    Kind
  • Jun 17, 2026Cynthia CollinsDirector
    Kind
  • Jun 17, 2026William W BrookeDirector
    Kind
  • Jun 17, 2026Patrick J BalthropDirector
    Kind
  • Jun 17, 2026Yasir B. Al-WakeelDirector
    Kind
  • Mar 17, 2026Douglas J SwirskyCHIEF FINANCIAL OFFICER
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 22, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by MXCT's officers and directors from 2021 up to November 14, 2025, 5 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%Nov 2, 2026 Latest filing
  • Capricorn Fund Managers Ltd
    Share of class7.70%
Fell to 5% or less (6)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Liontrust Investment Partners LLP13D4.90%Nov 2, 202613D
  • River Global Investors13D0.80%Aug 4, 202613D
  • BlackRock, Inc.1.30%Jul 29, 202613G/A
  • Mirabella Financial Services LLP0.00%Apr 10, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Cadian Capital Management, LP3.50%Feb 17, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+157%
  • Millennium Mgmt (Englander)
    In the quarter×28.0
  • D.E. Shaw
    In the quarter
  • Renaissance Technologies
    In the quarter+6.5%
  • AQR Capital
    In the quarter+54%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.71% of its shares outstanding were held short, +68.1% since the report before.

Shares held short
1.83M
1.71%
Since the report before1.09M on Sep 30, 2026
+68.1%
1.1
1.71M
More days to cover thanof 4,578 US-listed companies with enough volume
18%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 3.26M
  • Nov 15, 2023: Shares held short 2.97M
  • Nov 30, 2023: Shares held short 3.08M
  • Dec 15, 2023: Shares held short 4.00M
  • Dec 29, 2023: Shares held short 4.03M
  • Jan 12, 2024: Shares held short 3.18M
  • Jan 31, 2024: Shares held short 3.12M
  • Feb 15, 2024: Shares held short 3.17M
  • Feb 29, 2024: Shares held short 3.10M
  • Mar 15, 2024: Shares held short 3.12M
  • Mar 28, 2024: Shares held short 3.26M
  • Apr 15, 2024: Shares held short 3.29M
  • Apr 30, 2024: Shares held short 3.58M
  • May 15, 2024: Shares held short 3.48M
  • May 31, 2024: Shares held short 3.69M
  • Jun 14, 2024: Shares held short 3.41M
  • Jun 28, 2024: Shares held short 4.07M
  • Jul 15, 2024: Shares held short 4.19M
  • Jul 31, 2024: Shares held short 3.89M
  • Aug 15, 2024: Shares held short 3.83M
  • Aug 30, 2024: Shares held short 3.84M
  • Sep 13, 2024: Shares held short 3.79M
  • Sep 30, 2024: Shares held short 3.85M
  • Oct 15, 2024: Shares held short 3.51M
  • Oct 31, 2024: Shares held short 3.24M
  • Nov 15, 2024: Shares held short 3.32M
  • Nov 29, 2024: Shares held short 3.06M
  • Dec 13, 2024: Shares held short 3.16M
  • Dec 31, 2024: Shares held short 3.06M
  • Jan 15, 2025: Shares held short 3.00M
  • Jan 31, 2025: Shares held short 2.67M
  • Feb 14, 2025: Shares held short 2.77M
  • Feb 28, 2025: Shares held short 2.70M
  • Mar 14, 2025: Shares held short 2.98M
  • Mar 31, 2025: Shares held short 3.29M
  • Apr 15, 2025: Shares held short 3.48M
  • Apr 30, 2025: Shares held short 3.54M
  • May 15, 2025: Shares held short 3.83M
  • May 30, 2025: Shares held short 3.54M
  • Jun 13, 2025: Shares held short 3.56M
  • Jun 30, 2025: Shares held short 3.44M
  • Jul 15, 2025: Shares held short 3.48M
  • Jul 31, 2025: Shares held short 3.53M
  • Aug 15, 2025: Shares held short 3.61M
  • Aug 29, 2025: Shares held short 3.29M
  • Sep 15, 2025: Shares held short 3.55M
  • Sep 30, 2025: Shares held short 3.24M
  • Oct 15, 2025: Shares held short 3.43M
  • Oct 31, 2025: Shares held short 3.03M
  • Nov 14, 2025: Shares held short 3.01M
  • Nov 28, 2025: Shares held short 2.82M
  • Dec 15, 2025: Shares held short 2.68M
  • Dec 31, 2025: Shares held short 2.38M
  • Jan 15, 2026: Shares held short 2.50M
  • Jan 30, 2026: Shares held short 3.88M
  • Feb 13, 2026: Shares held short 5.09M
  • Feb 27, 2026: Shares held short 5.75M
  • Mar 13, 2026: Shares held short 5.49M
  • Mar 31, 2026: Shares held short 5.55M
  • Apr 15, 2026: Shares held short 5.41M
  • Apr 30, 2026: Shares held short 5.24M
  • May 15, 2026: Shares held short 4.72M
  • May 29, 2026: Shares held short 4.47M
  • Jun 15, 2026: Shares held short 4.24M
  • Jun 30, 2026: Shares held short 1.52M
  • Jul 15, 2026: Shares held short 1.41M
  • Jul 31, 2026: Shares held short 1.24M
  • Aug 14, 2026: Shares held short 1.23M
  • Aug 31, 2026: Shares held short 1.30M
  • Sep 15, 2026: Shares held short 1.17M
  • Sep 30, 2026: Shares held short 1.09M
  • Oct 15, 2026: Shares held short 1.83M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading24.2% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 24.2% of the shares in the reported trades were short sales, against 25.4% in the 14 before.

Last 14 sessionsOct 27, 2026 – Nov 13, 2026
24.2%
The 14 beforeOct 7, 2026 – Oct 26, 2026
25.4%
Change
-1.2 pts
Short sales a dayon average, of 724.9K shares
175.4K
More than atof 3,649 US-listed companies, same days
2%
Median of alleight in ten from 34.6% to 63.4%
50.1%
  • Oct 7, 2026: Short sales 30.4%
  • Oct 8, 2026: Short sales 71.3%
  • Oct 9, 2026: Short sales 55.2%
  • Oct 12, 2026: Short sales 30.2%
  • Oct 13, 2026: Short sales 43.7%
  • Oct 14, 2026: Short sales 32.7%
  • Oct 15, 2026: Short sales 6.8%
  • Oct 16, 2026: Short sales 13.3%
  • Oct 19, 2026: Short sales 15.7%
  • Oct 20, 2026: Short sales 20.6%
  • Oct 21, 2026: Short sales 21.7%
  • Oct 22, 2026: Short sales 13%
  • Oct 23, 2026: Short sales 12.6%
  • Oct 26, 2026: Short sales 12.6%
  • Oct 27, 2026: Short sales 9.7%
  • Oct 28, 2026: Short sales 23.2%
  • Oct 29, 2026: Short sales 19.4%
  • Oct 30, 2026: Short sales 25.4%
  • Nov 2, 2026: Short sales 16%
  • Nov 3, 2026: Short sales 15.1%
  • Nov 4, 2026: Short sales 12%
  • Nov 5, 2026: Short sales 17.2%
  • Nov 6, 2026: Short sales 40.9%
  • Nov 9, 2026: Short sales 26%
  • Nov 10, 2026: Short sales 29.5%
  • Nov 11, 2026: Short sales 31.1%
  • Nov 12, 2026: Short sales 32.4%
  • Nov 13, 2026: Short sales 20.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

2.22M Insiders' shares2.08% Of the company
  • Stanley C ErckDirector
    Directly428.7K
  • Douglas DoerflerPresident and CEO
    Directly333.2K
  • Richard DouglasDirector
    Directly261.0K
  • John Joseph JohnstonDirector
    Directly201.6K
  • William W BrookeDirector
    Directly181.3K
  • Maher MasoudPresident and CEO
    Directly175.0K
  • Douglas J SwirskyCHIEF FINANCIAL OFFICER
    Directly151.7K
  • Cynthia CollinsDirector
    Directly111.3K
  • Patrick J BalthropDirector
    Directly81.0K
  • Yasir B. Al-WakeelDirector
    Directly81.0K
  • Rekha HemrajaniDirector
    Directly70.3K
  • David I. SandovalGENERAL COUNSEL
    Directly64.2K
  • Ali SoleymannezhadChief Commercial Officer
    Directly59.4K
  • Thomas M. RossEVP, GLOBAL SALES
    Directly25.0K

A lower bound: it counts only the 14 officers and directors with a market trade since Nov 16, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

4 ETFs holding it0.00% The largest weight (VHT)
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

4 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

123 Managers, Q2 2026$78M Value of their positions
  • Q3 2025: Managers 112
  • Q4 2025: Managers 112
  • Q1 2026: Managers 132
  • Q2 2026: Managers 123

Institutional investors by quarter

The fund managers holding MXCT, quarter by quarter, from Q3 2021 to Q2 2025, 16 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 123 managers held 63.31M shares, worth $78M. During the quarter 27 opened a position, 36 closed one, 49 added and 28 trimmed.

The largest holders, Q2 2026

  • Capricorn Fund Managers
    In the quarter
  • Vitruvian Partners
    In the quarter
  • Vanguard Capital Management
    In the quarter+1.2%
  • Morgan Stanley
    In the quarter+0.2%
  • Mudita Advisors
    In the quarter
  • BlackRock
    In the quarter-65%
  • Brooklands Fund Management
    In the quarter+30%
  • BNP PARIBAS ASSET MANAGEMENT Holding
    In the quarter
  • Cadian Capital Management
    In the quarter+28%
  • Peapod Lane Capital
    In the quarter+60%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do MaxCyte's filings show?

Who buys and sells is one part of MaxCyte's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MXCT's shareholders

Didn't find what you were looking for?

Ask us
Have MXCT's insiders bought or sold?

From Jun 22, 2026 to Jun 22, 2026 MaxCyte's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold MXCT?

6 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $2.3M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.